Mountain Berg Ltd 4
4 · CONSTELLATION PHARMACEUTICALS INC · Filed Jul 23, 2018
Insider Transaction Report
Form 4
Mountain Berg Ltd
10% Owner
Transactions
- Conversion
Series F Preferred Stock
2018-07-23−750,000→ 0 total→ Common Stock (68,127 underlying) - Conversion
Series E Preferred Stock
2018-07-23−444,444→ 0 total→ Common Stock (51,905 underlying) - Conversion
Common Stock
2018-07-23+174,926→ 174,926 total - Conversion
Series E-1 Preferred Stock
2018-07-23−604,338→ 0 total→ Common Stock (54,894 underlying)
Footnotes (1)
- [F1]On July 23, 2018, the Series E-1 and Series F Preferred Stock converted into Common Stock on a 11.009-for-one basis, and the Series E Preferred Stock converted into Common Stock on a 8.56256-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series E, Series E-1 and Series F Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial pubic offering. The shares had no expiration date.